AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
IN-VITRO SUSCEPTIBILITY TESTING AND QUALITY-CONTROL PARAMETERS FOR SARAFLOXACIN (A-56620) - A FLUOROQUINOLONE USED FOR TREATMENT AND CONTROL OF COLIBACILLOSIS IN POULTRY
Authors: JONES RN ERWIN ME
Citation: Rn. Jones et Me. Erwin, IN-VITRO SUSCEPTIBILITY TESTING AND QUALITY-CONTROL PARAMETERS FOR SARAFLOXACIN (A-56620) - A FLUOROQUINOLONE USED FOR TREATMENT AND CONTROL OF COLIBACILLOSIS IN POULTRY, Diagnostic microbiology and infectious disease, 32(1), 1998, pp. 55-64
ANTIMICROBIAL ACTIVITY AND SPECTRUM INVESTIGATION OF 8 BROAD-SPECTRUMBETA-LACTAM DRUGS - A 1997 SURVEILLANCE TRIAL IN 102 MEDICAL-CENTERS IN THE UNITED-STATES
Authors: JONES RN PFALLER MA DOERN GV ERWIN ME HOLLIS RJ
Citation: Rn. Jones et al., ANTIMICROBIAL ACTIVITY AND SPECTRUM INVESTIGATION OF 8 BROAD-SPECTRUMBETA-LACTAM DRUGS - A 1997 SURVEILLANCE TRIAL IN 102 MEDICAL-CENTERS IN THE UNITED-STATES, Diagnostic microbiology and infectious disease, 30(3), 1998, pp. 215-228
RB-SR AGES OF DIAGENESIS OF MG-RICH CLAY IN PERMIAN SEDIMENTS, PALO-DURO BASIN, TEXAS PANHANDLE, USA
Authors: LONG LE ERWIN ME FISHER RS
Citation: Le. Long et al., RB-SR AGES OF DIAGENESIS OF MG-RICH CLAY IN PERMIAN SEDIMENTS, PALO-DURO BASIN, TEXAS PANHANDLE, USA, Journal of sedimentary research, 67(1), 1997, pp. 225-234
AVOPARCIN, A GLYCOPEPTIDE USED IN ANIMAL FOODS - ANTIMICROBIAL SPECTRUM AND POTENCY TESTED AGAINST HUMAN ISOLATES FROM THE UNITED-STATES
Authors: CORMICAN MG ERWIN ME JONES RN
Citation: Mg. Cormican et al., AVOPARCIN, A GLYCOPEPTIDE USED IN ANIMAL FOODS - ANTIMICROBIAL SPECTRUM AND POTENCY TESTED AGAINST HUMAN ISOLATES FROM THE UNITED-STATES, Diagnostic microbiology and infectious disease, 29(4), 1997, pp. 241-248
NOSOCOMIAL ENTEROCOCCAL BLOOD-STREAM INFECTIONS IN THE SCOPE PROGRAM - ANTIMICROBIAL RESISTANCE, SPECIES OCCURRENCE, MOLECULAR TESTING RESULTS, AND LABORATORY TESTING ACCURACY
Authors: JONES RN MARSHALL SA PFALLER MA WILKE WW HOLLIS RJ ERWIN ME EDMOND MB WENZEL RP TOMASULO M WILLIAMS C WORD J CAVALIERI S LORENZEN A KOGA D WARDELL P BALTZER R ZIEMANN S SETH VK BOURBEAU P DAHLMAN M MOORE J SHARP S JOHNSON P STONE J MCNALLY M SHAPIRO M TJOELKER R SEWELL D DAVENPORT ML GROUT C DOCKEN L OHRT D ANDERSON D LEONG D OCZKI V PULLEN G CHAPMAN J GAMBLE S DELLALATTA P FRACARO M FERWERDA H OTAL T HERNANDEZ S HERWALDT L BLOCK J MEYER L TEMME L SKATES S BINGHAM J LESLIE V JOHNSON MA NODDIN P THEIS J VERHOEREN V BHARANI N CUTLER CJ SAILSBURY D STECKEL P BUTLER J OTTINGER T VALDON C VIGIONESE G VYEDA C EYHERABIDE S LANGENFELD S GARDNER M SCHULTE M MACARTHUR MA SOUZA P KOLL B MOTYL M LAMPMAN M MORRIS B PAGE D BANE L PIERCE G TAYLOR N GIELERAK P EDMUND M WALLACE S WENZEL R VARLIJEN A SERVIS K FERRANTI J DVORAK J BRENEISER S
Citation: Rn. Jones et al., NOSOCOMIAL ENTEROCOCCAL BLOOD-STREAM INFECTIONS IN THE SCOPE PROGRAM - ANTIMICROBIAL RESISTANCE, SPECIES OCCURRENCE, MOLECULAR TESTING RESULTS, AND LABORATORY TESTING ACCURACY, Diagnostic microbiology and infectious disease, 29(2), 1997, pp. 95-102
IN-VITRO ANTIMICROBIAL ACTIVITY OF RU-59863, A C-7 CATECHOL SUBSTITUTED CEPHALOSPORIN
Authors: ERWIN ME VARNAM D JONES RN
Citation: Me. Erwin et al., IN-VITRO ANTIMICROBIAL ACTIVITY OF RU-59863, A C-7 CATECHOL SUBSTITUTED CEPHALOSPORIN, Diagnostic microbiology and infectious disease, 28(2), 1997, pp. 93-100
IN-VITRO ACTIVITY AND SPECTRUM OF LY333328, A NOVEL GLYCOPEPTIDE DERIVATIVE
Authors: JONES RN BARRET MS ERWIN ME
Citation: Rn. Jones et al., IN-VITRO ACTIVITY AND SPECTRUM OF LY333328, A NOVEL GLYCOPEPTIDE DERIVATIVE, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 488-493
SUSCEPTIBILITY TESTING INTERPRETIVE CRITERIA FOR LEVOFLOXACIN WHEN TESTING RESPIRATORY PATHOGENS, HAEMOPHILUS-INFLUENZAE AND MORAXELLA-CATARRHALIS
Authors: CORMICAN MG ERWIN ME MARSHALL SA JONES RN
Citation: Mg. Cormican et al., SUSCEPTIBILITY TESTING INTERPRETIVE CRITERIA FOR LEVOFLOXACIN WHEN TESTING RESPIRATORY PATHOGENS, HAEMOPHILUS-INFLUENZAE AND MORAXELLA-CATARRHALIS, Diagnostic microbiology and infectious disease, 24(3), 1996, pp. 155-160
QUALITY-CONTROL GUIDELINES FOR AMOXICILLIN, AMOXICILLIN-CLAVULANATE, AZITHROMYCIN, PIPERACILLIN-TAZOBACTAM, ROXITHROMYCIN, TICARCILLIN, TICARCILLIN-CLAVULANATE, TROVAFLOXACIN (CP-99,219), U-100592, AND U-100766 FOR VARIOUS TIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS SUSCEPTIBILITY TESTING METHODS - RESULTS FROM MULTICENTER TRIALS
Authors: WORTH S ERWIN ME JONES RN WANGER A WASHINGTON JA DOERN GV HINDLER J HAUGEN TH APPELBAUM PC JACOBS MR MURRAY P SEWELL D
Citation: S. Worth et al., QUALITY-CONTROL GUIDELINES FOR AMOXICILLIN, AMOXICILLIN-CLAVULANATE, AZITHROMYCIN, PIPERACILLIN-TAZOBACTAM, ROXITHROMYCIN, TICARCILLIN, TICARCILLIN-CLAVULANATE, TROVAFLOXACIN (CP-99,219), U-100592, AND U-100766 FOR VARIOUS TIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS SUSCEPTIBILITY TESTING METHODS - RESULTS FROM MULTICENTER TRIALS, Diagnostic microbiology and infectious disease, 24(2), 1996, pp. 87-91
FALSE RESISTANCE TO METRONIDAZOLE BY E-TEST AMONG ANAEROBIC-BACTERIA INVESTIGATIONS OF CONTRIBUTING TEST CONDITIONS AND MEDIUM QUALITY
Authors: CORMICAN MG ERWIN ME JONES RN
Citation: Mg. Cormican et al., FALSE RESISTANCE TO METRONIDAZOLE BY E-TEST AMONG ANAEROBIC-BACTERIA INVESTIGATIONS OF CONTRIBUTING TEST CONDITIONS AND MEDIUM QUALITY, Diagnostic microbiology and infectious disease, 24(2), 1996, pp. 117-119
CRITICAL-APPRAISAL OF E-TEST FOR THE DETECTION OF FLUOROQUINOLONE RESISTANCE
Authors: JONES RN ERWIN ME CROCO JL
Citation: Rn. Jones et al., CRITICAL-APPRAISAL OF E-TEST FOR THE DETECTION OF FLUOROQUINOLONE RESISTANCE, Journal of antimicrobial chemotherapy, 38(1), 1996, pp. 21-25
INTERLABORATORY EVALUATION OF ETEST METHOD FOR TESTING ANTIFUNGAL SUSCEPTIBILITIES OF PATHOGENIC YEASTS TO 5 ANTIFUNGAL AGENTS BY USING CASITONE AGAR AND SOLIDIFIED RPMI-1640 MEDIUM WITH 2-PERCENT GLUCOSE
Authors: ESPINELINGROFF A PFALLER M ERWIN ME JONES RN
Citation: A. Espinelingroff et al., INTERLABORATORY EVALUATION OF ETEST METHOD FOR TESTING ANTIFUNGAL SUSCEPTIBILITIES OF PATHOGENIC YEASTS TO 5 ANTIFUNGAL AGENTS BY USING CASITONE AGAR AND SOLIDIFIED RPMI-1640 MEDIUM WITH 2-PERCENT GLUCOSE, Journal of clinical microbiology, 34(4), 1996, pp. 848-852
IN-VITRO ANTIMICROBIAL ACTIVITIES AND SPECTRA OF U-100592 AND U-100766, 2 NOVEL FLUORINATED OXAZOLIDINONES
Authors: JONES RN JOHNSON DM ERWIN ME
Citation: Rn. Jones et al., IN-VITRO ANTIMICROBIAL ACTIVITIES AND SPECTRA OF U-100592 AND U-100766, 2 NOVEL FLUORINATED OXAZOLIDINONES, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 720-726
EVALUATION OF THE ETEST FOR DETERMINATIONS OF ANTIMICROBIAL SPECTRUM AND POTENCY AGAINST ANAEROBES ASSOCIATED WITH BACTERIAL VAGINOSIS AND PERITONITIS
Authors: CROCO JL ERWIN ME JENNINGS JM PUTNAM LR JONES RN
Citation: Jl. Croco et al., EVALUATION OF THE ETEST FOR DETERMINATIONS OF ANTIMICROBIAL SPECTRUM AND POTENCY AGAINST ANAEROBES ASSOCIATED WITH BACTERIAL VAGINOSIS AND PERITONITIS, Clinical infectious diseases, 20, 1995, pp. 339-341
BACTERICIDAL ACTIVITY OF CEFOTAXIME, DESACETYLCEFOTAXIME, RIFAMPIN, AND VARIOUS COMBINATIONS TESTED AT CEREBROSPINAL-FLUID LEVELS AGAINST PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE
Authors: CORMICAN MG ERWIN ME JONES RN
Citation: Mg. Cormican et al., BACTERICIDAL ACTIVITY OF CEFOTAXIME, DESACETYLCEFOTAXIME, RIFAMPIN, AND VARIOUS COMBINATIONS TESTED AT CEREBROSPINAL-FLUID LEVELS AGAINST PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE, Diagnostic microbiology and infectious disease, 22(1-2), 1995, pp. 119-123
EMERGING MULTIPLY RESISTANT ENTEROCOCCI AMONG CLINICAL ISOLATES .1. PREVALENCE DATA FROM 97 MEDICAL-CENTER SURVEILLANCE STUDY IN THE UNITED-STATES
Authors: JONES RN SADER HS ERWIN ME ANDERSON SC ALDRIDGE KA ALLEN S ANHALT J APPELBAUM P ARRINGTON KL AYERS L BAKER C BEAVIS K BERGER J BERTHOLD G BIRNBAUM M BOYLE J BRECHER S BRECKENRIDGE R BROWN W BRUCKNER D CARROLL K CHAUDHARY S CLEARY T COCKERILL F COYLE M CRAWFORD V DALTON H DOERN G EDBERG S GELFAND M GERLACH EH GOODMAN N GORZYNSKI E GREEN P GROSCHEL D HANFF P HANNA B HARRELL L HAUGEN T HEAGREY M HUMPHRIES J ISENBERG H JENKINS S JONES E JORGENSEN J KAUFFMAN C KEISER J KOCKA F KOMINOS S LEVISON M LOCKWOOD W MANOS J MARTIN W MCLAUGHLIN J METCHOCK B MICKELSEN P MOODY J MORELLO J MOSTOW S MOTYL M MURRAY B MURRAY PR NOLTE F PARK C PEZZLO M PRICE M PUSCSH A REED K REIMER L RINALDI M RISTUCCIA A ROBINSON A ROSATI L SAUBOLLE M SCHALHAB J SCHULTZ G SCHWALBE R SEWELL D SHALES D SIERRA M SINNOTT J SLIFKIN M SMITH L SPIEGEL C STANECK J STEELEMOORE L STEIN G STEVENS D STRATTON C TAN J THOMAS J WAITES K WEINSTEIN M WELCH W WIN W WOODS G WRIGHT L YUNGBLUTH M ZWADYK P
Citation: Rn. Jones et al., EMERGING MULTIPLY RESISTANT ENTEROCOCCI AMONG CLINICAL ISOLATES .1. PREVALENCE DATA FROM 97 MEDICAL-CENTER SURVEILLANCE STUDY IN THE UNITED-STATES, Diagnostic microbiology and infectious disease, 21(2), 1995, pp. 85-93
EMERGING MULTIPLY RESISTANT ENTEROCOCCI AMONG CLINICAL ISOLATES .2. VALIDATION OF THE ETEST TO RECOGNIZE GLYCOPEPTIDE-RESISTANT STRAINS
Authors: JONES RN ERWIN ME ANDERSON SC
Citation: Rn. Jones et al., EMERGING MULTIPLY RESISTANT ENTEROCOCCI AMONG CLINICAL ISOLATES .2. VALIDATION OF THE ETEST TO RECOGNIZE GLYCOPEPTIDE-RESISTANT STRAINS, Diagnostic microbiology and infectious disease, 21(2), 1995, pp. 95-100
ANTIMICROBIAL ACTIVITY OF 11 NEWER AND INVESTIGATIONAL DRUGS TESTED AGAINST AEROBIC ISOLATES FROM SPONTANEOUS BACTERIAL PERITONITIS
Authors: SADER HS RUNYON BA ERWIN ME JONES RN
Citation: Hs. Sader et al., ANTIMICROBIAL ACTIVITY OF 11 NEWER AND INVESTIGATIONAL DRUGS TESTED AGAINST AEROBIC ISOLATES FROM SPONTANEOUS BACTERIAL PERITONITIS, Diagnostic microbiology and infectious disease, 21(2), 1995, pp. 105-110
MULTICENTER CLINICAL LABORATORY EVALUATION OF A BETA-LACTAMASE DISK ASSAY EMPLOYING A NOVEL CHROMOGENIC CEPHALOSPORIN, S1
Authors: DOERN GV JONES RN GERLACH EH WASHINGTON JA BIEDENBACH DJ BRUEGGEMANN A ERWIN ME KNAPP C RAYMOND J
Citation: Gv. Doern et al., MULTICENTER CLINICAL LABORATORY EVALUATION OF A BETA-LACTAMASE DISK ASSAY EMPLOYING A NOVEL CHROMOGENIC CEPHALOSPORIN, S1, Journal of clinical microbiology, 33(6), 1995, pp. 1665-1667
EVALUATION OF THE ETEST FOR ANTIMICROBIAL SPECTRUM AND POTENCY DETERMINATIONS OF ANAEROBES ASSOCIATED WITH BACTERIAL VAGINOSIS AND PERITONITIS
Authors: CROCO JL ERWIN ME JENNINGS JM PUTNAM LR JONES RN
Citation: Jl. Croco et al., EVALUATION OF THE ETEST FOR ANTIMICROBIAL SPECTRUM AND POTENCY DETERMINATIONS OF ANAEROBES ASSOCIATED WITH BACTERIAL VAGINOSIS AND PERITONITIS, Diagnostic microbiology and infectious disease, 20(4), 1994, pp. 213-219
UPDATE OF LOMEFLOXACIN IN-VITRO ACTIVITY AND SPECTRUM - A MULTICENTERTRIAL TESTING CONTEMPORARY PATHOGENS FOLLOWING FOOD-AND-DRUG-ADMINISTRATION VALIDATION GUIDELINES
Authors: JONES RN SADER HS ERWIN ME ALDRIDGE K DOERN GV HINDLER J FRITSCHE TR MURRAY PR SEWELL D STEIN G WASHINGTON JA
Citation: Rn. Jones et al., UPDATE OF LOMEFLOXACIN IN-VITRO ACTIVITY AND SPECTRUM - A MULTICENTERTRIAL TESTING CONTEMPORARY PATHOGENS FOLLOWING FOOD-AND-DRUG-ADMINISTRATION VALIDATION GUIDELINES, Diagnostic microbiology and infectious disease, 20(2), 1994, pp. 93-98
CEFQUINOME (HR 111V) - IN-VITRO EVALUATION OF A BROAD-SPECTRUM CEPHALOSPORIN INDICATED FOR INFECTIONS IN ANIMALS
Authors: MURPHY SP ERWIN ME JONES RN
Citation: Sp. Murphy et al., CEFQUINOME (HR 111V) - IN-VITRO EVALUATION OF A BROAD-SPECTRUM CEPHALOSPORIN INDICATED FOR INFECTIONS IN ANIMALS, Diagnostic microbiology and infectious disease, 20(1), 1994, pp. 49-55
PREVALENCE OF IMPORTANT PATHOGENS AND ANTIMICROBIAL ACTIVITY OF PARENTERAL DRUGS AT NUMEROUS MEDICAL-CENTERS IN THE UNITED-STATES .1. STUDYON THE THREAT OF EMERGING RESISTANCES - REAL OR PERCEIVED
Authors: JONES RN KEHRBERG EN ERWIN ME ANDERSON SC BEAVIS K BERMAN M BOURBEAU P SINNOTT J CANAWATI H CAVALIERI S COCKERILL F DELLALATTA P DENYS G DOERN G FORBES B GAMBLE S GOODMAN N HAUGEN T HINDLER J HUMPHRIES J JOSEPHSON S KAUFFMAN C LIBERTINE C MAUNEY C METCHOCK B MICHELSON P MURRAY P NEEDHAM C OELSCHDAEGER R PRICE M SACEANU C SCHWALBE R SEGRETI J SEWELL D SIERRA M SLIFKIN M SNYDMAN D SOUTHERN P SPIEGEL C STEELEMOORE L STEIN G STRATTON C WANGER A WASHINGTON J WASILAUSKAS B WEINSTEIN M
Citation: Rn. Jones et al., PREVALENCE OF IMPORTANT PATHOGENS AND ANTIMICROBIAL ACTIVITY OF PARENTERAL DRUGS AT NUMEROUS MEDICAL-CENTERS IN THE UNITED-STATES .1. STUDYON THE THREAT OF EMERGING RESISTANCES - REAL OR PERCEIVED, Diagnostic microbiology and infectious disease, 19(4), 1994, pp. 203-215
ETEST FOR ROUTINE CLINICAL ANTIMICROBIAL SUSCEPTIBILITY TESTING OF RAPID-GROWING MYCOBACTERIA ISOLATES
Authors: KOONTZ FP ERWIN ME BARRETT MS JONES RN
Citation: Fp. Koontz et al., ETEST FOR ROUTINE CLINICAL ANTIMICROBIAL SUSCEPTIBILITY TESTING OF RAPID-GROWING MYCOBACTERIA ISOLATES, Diagnostic microbiology and infectious disease, 19(3), 1994, pp. 183-186
MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS
Authors: BALE MJ JONES RN ERWIN ME MURRAY PR WASHINGTON JA GERLACH EH THORNSBERRY C HINDLER J DOERN GV
Citation: Mj. Bale et al., MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS, Diagnostic microbiology and infectious disease, 19(1), 1994, pp. 65-68
Risultati: 1-25 | 26-38